Status: Recruiting
A Long Term Follow-up Study of TScan TCR-T Products
The purpose of this Long-Term Follow-Up (LTFU) study is to monitor participants who have previously received TSC-100 or TSC-101 TCR-T therapies in the TSCAN-001 study. Participants will be monitored for 15 years from the date of TCR-T cell therapy administration to assess long-term safety and efficacy.
Participants needed: 1,000
Trial details
Age: 18-110Biological sex: AllType: ObservationalSponsor: TScan Therapeutics, Inc.Updated: Sep 10, 2025Locations: 2
Eligibility criteria
Participants who received a TCR-T cellular therapy in a clinical study sponsored... [+1]
None